These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22619394)

  • 21. Screening and brief intervention for alcohol and other abuse.
    Harris SK; Louis-Jacques J; Knight JR
    Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interactive role of distress tolerance and borderline personality disorder in suicide attempts among substance users in residential treatment.
    Anestis MD; Gratz KL; Bagge CL; Tull MT
    Compr Psychiatry; 2012 Nov; 53(8):1208-16. PubMed ID: 22595187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric properties of the Turkish versions of the Drug Use Disorders Identification Test (DUDIT) and the Drug Abuse Screening Test (DAST-10) in the prison setting.
    Evren C; Ogel K; Evren B; Bozkurt M
    J Psychoactive Drugs; 2014; 46(2):140-6. PubMed ID: 25052790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personality and psychopathology of drug addicts in Puerto Rico.
    Porrata JL; Rosa A
    Psychol Rep; 2000 Feb; 86(1):275-80. PubMed ID: 10778280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Marijuana Screening Inventory (MSI-X): concurrent, convergent and discriminant validity with multiple measures.
    Alexander D; Leung P
    Am J Drug Alcohol Abuse; 2006; 32(3):351-78. PubMed ID: 16864468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychometric properties of the decisional balance for patient choice in substance abuse treatment.
    Finnell DS; Lee J
    Issues Ment Health Nurs; 2011; 32(4):243-9. PubMed ID: 21355759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
    Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of screening instruments in detecting substance use disorders among prisoners.
    Peters RH; Greenbaum PE; Steinberg ML; Carter CR; Ortiz MM; Fry BC; Valle SK
    J Subst Abuse Treat; 2000 Jun; 18(4):349-58. PubMed ID: 10812308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
    Mestre-Pintó JI; Domingo-Salvany A; Martín-Santos R; Torrens M;
    Eur Addict Res; 2014; 20(1):41-8. PubMed ID: 23921461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the substance abuse screener in American Sign Language (SAS--ASL).
    Guthmann D; Lazowski LE; Moore D; Heinemann AW; Embree J
    Rehabil Psychol; 2012 May; 57(2):140-8. PubMed ID: 22686552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotherapy with dual diagnosis patients: working with denial.
    Levy M
    J Subst Abuse Treat; 1993; 10(6):499-504. PubMed ID: 8308933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The validity of the psychopathic personality inventory--revised in a community sample.
    Uzieblo K; Verschuere B; Van den Bussche E; Crombez G
    Assessment; 2010 Sep; 17(3):334-46. PubMed ID: 20040727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The European Adolescent Assessment Dialogue (EuroADAD): a psychometric evaluation.
    Czobor P; Bácskai E; Oberg D; Haack MJ; Gerevich J
    Eur Addict Res; 2011; 17(6):302-15. PubMed ID: 21934309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance abuse and criminality.
    Sinha R; Easton C
    J Am Acad Psychiatry Law; 1999; 27(4):513-26. PubMed ID: 10638781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopathology and addictive disorders. The specific case of antisocial personality disorder.
    Hesselbrock V; Meyer R; Hesselbrock M
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():179-91. PubMed ID: 1535930
    [No Abstract]   [Full Text] [Related]  

  • 38. Establishing the validity of the personality assessment inventory drug and alcohol scales in a corrections sample.
    Patry MW; Magaletta PR; Diamond PM; Weinman BA
    Assessment; 2011 Mar; 18(1):50-9. PubMed ID: 20484714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of the drug abuse screening test for adolescents (DAST-A).
    Martino S; Grilo CM; Fehon DC
    Addict Behav; 2000; 25(1):57-70. PubMed ID: 10708319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of the Substance Abuse Subtle Screening Inventory-3 for use with individuals with brain injury.
    Arenth PM; Bogner JA; Corrigan JD; Schmidt L
    Brain Inj; 2001 Jun; 15(6):499-510. PubMed ID: 11394969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.